Medicine
Palonosetron 0.075 mg/1.5 mL injection
Palonosetron 0.075 mg/1.5 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20°C to 25°C (68°F to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Palonosetron
- Brand
- Sold under the generic name
- Strength
- 0.075 mg/1.5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 vials of 1.5 mL
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaQilu Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20°C to 25°C (68°F to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AA05 Palonosetron
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 March 2018
- Identifiers
- RxCUI 1728050, 1728055DailyMed set ID 991b8452-852c-c55c-7b1b-e97c4964777a, 633abdc2-a942-4eb2-a0f8-f9f4e727211eNDC 55111-694, 67184-0515Application ANDA201533, ANDA205648
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial, single-use in 1 carton / 1.5 mL in 1 vial, single-use | 55111-694-19 | Dr. Reddy's LaboratoriesIndia | 23 March 2018 |
| 5 vial in 1 carton / 1.5 mL in 1 vial | 67184-0515-2 | Qilu Pharmaceutical | 19 September 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Palonosetron
Clinical summary
Palonosetron is a serotonin-3 receptor antagonist. It is available as injection for intravenous use. MedsAcross supplies Palonosetron for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PalonosetronFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- palonosetron hydrochloride prescribing information (Cipla) · U.S. National Library of Medicine, DailyMed
- Aloxi: European public assessment report (EPAR) · European Medicines Agency
- Palonosetron Accord: European public assessment report (EPAR) · European Medicines Agency
Need Palonosetron 0.075 mg/1.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.